Loading clinical trials...

The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV

NCT07466836•Tyson Perez, DC, PhD

View on ClinicalTrials.gov

Summary

The main aim of this pilot trial is to investigate the feasibility of undertaking a randomized controlled trial involving adults living with HIV. Additionally, this trial will explore potential change differences in self-reported quality of life and blood-derived immune markers between a chiropractic care group and no treatment controls.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Aged 18 or older
•Medically confirmed HIV diagnosis
•Willing to complete online surveys
•Willing to share lab results
•Willing to be randomized to either once weekly chiropractic care or a no treatment control condition

Exclusion Criteria

•Participating in another clinical/behavioral trial related to HIV
•Receiving chiropractic care elsewhere
•Involved in litigation related to a physical, health-related injury
•Has severe osteoporosis or recent spinal fracture

Locations (1)

Life University

Marietta, Georgia, United States

Key Dates

Start Date

April 1, 2026

Primary Completion Date

February 1, 2027

Completion Date

February 1, 2027

Last Updated

March 12, 2026

Enrollment

ESTIMATED participants

Conditions

Human Immunodeficiency Virus (HIV)

Interventions

Chiropractic Care

PROCEDURE

Contacts

Research Programs & Grants Administrator

CONTACT

678-331-4527 angela.seckington@life.edu

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT07071623

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis

View study

RECRUITINGPHASE2

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

NCT04375800

Human Immunodeficiency Virus (HIV) Infection

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 12, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV

Inclusion Criteria

Exclusion Criteria

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

Strategies to AchieVe Viral Suppression for Youth With HIV

Project neuroARTEMIS

Persuasive Health Communication Intervention for HIV/HCV